| Application no. and date | 13849295.4 (espacenet) (Federated) (European Patent Register), 20131025 | | Patent/reg. no. and date | DK/EP 2911669, 20240410 | | Publication date | 20150902 | | Priority no. and date | US 201261719202 P, 20121026 | | EP pub. no. and date |
EP 2911669 20150902 | | Effective date | | | Applicant/owner | The University of Chicago, 5801 South Ellis Avenue
Chicago, IL 60637, US | | Applicant ref. no. | | | Inventor | GAJEWSKI, Thomas F., c/o The University Of Chicago
5801 S. Ellis Ave.
Chicago, IL 60637, US,
SPRANGER, Stefani, c/o The University Of Chicago
5801 S. Ellis Ave.
Chicago, IL 60637, US,
LEUNG, Michael, c/o The University Of Chicago
5801 S. Ellis Ave.
Chicago, IL 60637, US | | Representative | | | Opponent | | | IPC Class | A61K 31/41 (2006.01) , A61K 31/4245 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) | | Title | SYNERGISTIC COMBINATION OF IMMUNOLOGIC INHIBITORS FOR THE TREATMENT OF CANCER | | Int. application no. | US2013066936 | | Int. publication no. | WO2014066834 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
